Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Scientific Reports
|
December 8, 2018
The spatial epidemiology of sickle-cell anaemia in India
Carinna Hockham, Samir Bhatt, Roshan Colah, et al.
NPJ Digital Medicine
|
July 17, 2025
Identifying clusters of people with Multiple Long-Term Conditions using Large Language Models: a population-based study
Alexander Smith, Thomas Beaney, Carinna Hockham, et al.
Clinical Kidney Journal
|
June 6, 2022
Sex differences in chronic kidney disease prevalence in Asia: a systematic review and meta-analysis
Carinna Hockham, Lexia Bao, Anushree Tiku, et al.
Lancet (London, England)
|
November 3, 2024
Haemodiafiltration versus haemodialysis for kidney failure: an individual patient data meta-analysis of randomised controlled trials
Robin W M Vernooij, Carinna Hockham, Giovanni Strippoli, et al.
Public Health Reviews
|
October 10, 2022
Nation-Wide Routinely Collected Health Datasets in China: A Scoping Review
Yishu Liu, Shaoming Xiao, Xuejun Yin, et al.
Frontiers in Pharmacology
|
March 25, 2022
Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction
Anna Campain, Carinna Hockham, Louisa Sukkar, et al.
Internal Medicine Journal
|
October 4, 2020
Risk factors for incident kidney disease in older adults: an Australian prospective population-based study
Amy Kang, Louisa Sukkar, Carinna Hockham, et al.
BMJ Global Health
|
January 26, 2022
Prevalence of chronic kidney disease in Asia: a systematic review and analysis
Thaminda Liyanage, Tadashi Toyama, Carinna Hockham, et al.
Diabetes Care
|
March 13, 2020
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study
Louisa Sukkar, Amy Kang, Carinna Hockham, et al.
Diabetologia
|
August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS Program
Tamara K Young, Jing-Wei Li, Amy Kang, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Scientific Reports
|
December 8, 2018
The spatial epidemiology of sickle-cell anaemia in India
Carinna Hockham, Samir Bhatt, Roshan Colah, et al.
NPJ Digital Medicine
|
July 17, 2025
Identifying clusters of people with Multiple Long-Term Conditions using Large Language Models: a population-based study
Alexander Smith, Thomas Beaney, Carinna Hockham, et al.
Clinical Kidney Journal
|
June 6, 2022
Sex differences in chronic kidney disease prevalence in Asia: a systematic review and meta-analysis
Carinna Hockham, Lexia Bao, Anushree Tiku, et al.
Lancet (London, England)
|
November 3, 2024
Haemodiafiltration versus haemodialysis for kidney failure: an individual patient data meta-analysis of randomised controlled trials
Robin W M Vernooij, Carinna Hockham, Giovanni Strippoli, et al.
Public Health Reviews
|
October 10, 2022
Nation-Wide Routinely Collected Health Datasets in China: A Scoping Review
Yishu Liu, Shaoming Xiao, Xuejun Yin, et al.
Frontiers in Pharmacology
|
March 25, 2022
Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction
Anna Campain, Carinna Hockham, Louisa Sukkar, et al.
Internal Medicine Journal
|
October 4, 2020
Risk factors for incident kidney disease in older adults: an Australian prospective population-based study
Amy Kang, Louisa Sukkar, Carinna Hockham, et al.
BMJ Global Health
|
January 26, 2022
Prevalence of chronic kidney disease in Asia: a systematic review and analysis
Thaminda Liyanage, Tadashi Toyama, Carinna Hockham, et al.
Diabetes Care
|
March 13, 2020
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 Study
Louisa Sukkar, Amy Kang, Carinna Hockham, et al.
Diabetologia
|
August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA<sub>1c</sub>, disease duration and treatment intensity: results from the CANVAS Program
Tamara K Young, Jing-Wei Li, Amy Kang, et al.
Page
of 4